Specialists for MALT lymphoma

58 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Markus Raderer, Prof
Rare Disease / Clinical Research
Department of Internal Medicine I
PI×2
David Maloney
Rare Disease / Clinical Research
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
PI×11
Shuhua Yi, Dr
Rare Disease / Clinical Research
Institute of Hematology & Blood Diseases Hospital, Chinese
PI×1
Jun Shi
Rare Disease / Clinical Research
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
PI×3 172
Paolo Caimi, MD, M.D
Rare Disease / Clinical Research
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
CLEVELAND, OH
PI×5
Thomas G. Martin, MD
Rare Disease / Clinical Research
University of California, San Francisco
PI×4
Gottfried von Keudell, MD, PhD
Rare Disease / Clinical Research
Beth Israel Deaconess Medical Center
PI×3
Rahul Banerjee, MD, M.D
Rare Disease / Clinical Research
Fred Hutch/University of Washington Cancer Consortium
SEATTLE, WA
PI×2
Paul Martin
Rare Disease / Clinical Research
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
PI×3 73
Bita Esmaeli, MD, M.D
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
SPRING, TX
PI×3
Lihua Budde, MD, PhD
Rare Disease / Clinical Research
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
DUARTE, CA
PI×1
James L. Rubenstein, MD, PhD
Rare Disease / Clinical Research
University of California, San Francisco
PI×2
Shaji Kumar
Rare Disease Specialist
Mayo Clinic
Anchorage, Alaska
PI×7
Jennifer Amengual, MD, M.D
Rare Disease / Clinical Research
Columbia University
NEW YORK, NY
PI×2
Beth Christian, MD
Rare Disease / Clinical Research
Ohio State University
PI×3
Amanda M Termuhlen, MD
Rare Disease / Clinical Research
Children's Oncology Group
MINNEAPOLIS, MN
PI×1 1
Thomas Witzig, M.D
Rare Disease / Clinical Research
Mayo Clinic
ROCHESTER, MN
PI×5
Jorge Chaves, M.D, Ph.D
Rare Disease / Clinical Research
Northwest Medical Specialities, PLLC
PI×1
Minoti Hiremath, MD
Rare Disease / Clinical Research
Atara Biotherapeutics
PI×2
JS Kim, M.D, Ph.D
Rare Disease / Clinical Research
Severance Hospital, Yonsei University Health System
PI×1
JO Lee, M.D, Ph.D
Rare Disease / Clinical Research
Seoul National University Bundang Hospital
PI×1
Emily Curran, M.D, Ph.D
Rare Disease / Clinical Research
University of Cincinnati
PI×1
SJ Kim, M.D, Ph.D
Rare Disease / Clinical Research
Samsung Medical Center
PI×1
DH Yang, M.D, Ph.D
Rare Disease / Clinical Research
Chonnam National University Hospital
PI×1
TM Kim, M.D, Ph.D
Rare Disease / Clinical Research
Seoul National University Hospital
PI×1
DH Yoon, M.D, Ph.D
Rare Disease / Clinical Research
Asan Medical Center
PI×1
EY Lee, M.D, M.S
Rare Disease / Clinical Research
National Cancer Center
PI×1
WS Lee, M.D, Ph.D
Rare Disease / Clinical Research
Inje University
PI×1
Denise Pereira, MD
University of Miami Sylvester Comprehensive Cancer Center
MIAMI, FL
QC-verified PI×1
Gideon Steinbach
M.D. Anderson Cancer Center
SEATTLE, WA
QC-verified PI×1
Yazeed Sawalha, M.D
Ohio State University Comprehensive Cancer Center
COLUMBUS, OH
QC-verified PI×3
Andrés JM Ferreri
San Raffaele Scientific Institute, Milano, Italy
QC-verified PI×4
Sung-Hsin Kuo
National Taiwan University Hospital
QC-verified PI×4
Felipe Samaniego, MD, MPH
M.D. Anderson Cancer Center
HOUSTON, TX
QC-verified PI×3
Dae Seog Heo
Seoul National University Hospital
QC-verified PI×2
Sung Yong Oh
Dong-A University Hospital
QC-verified PI×2
Guillaume CARTRON
Lymphoma Study Association
QC-verified PI×2
junning Cao, Ph.D
Fudan University
QC-verified PI×1
Luciano Cascione
Foundation for the Institute of Oncology Research
QC-verified PI×1
Carlos Montalbán
Ramon y Cajal Hospital
QC-verified PI×1
Suzin Mayerson
LifeTime Pharmaceuticals
QC-verified PI×1
Karla Chaloupka, RRT
University Hospital Zurich, Ophtalmic Clinic
QC-verified PI×1
Dai Chihara, MD, PhD
M.D. Anderson Cancer Center
HOUSTON, TX
QC-verified PI×1
Hervé TILLY
Lymphoma Study Association
QC-verified PI×1
Francesco Turturro
LSUHSC-S
QC-verified PI×1
Yizhen Liu
Fudan University
QC-verified PI×1
Margaret M. Briehl
University of Arizona
QC-verified PI×1
Wei Ding
Mayo Clinic in Rochester
QC-verified PI×2
Patrice P. Carde
Gustave Roussy, Cancer Campus, Grand Paris
QC-verified PI×1
Katsuya Sugizaki
Drug Fostering and Evolution Coordination Department, Eisai Co., Ltd.
QC-verified PI×1
Andreas Buck
University Hospital Würzburg, Department of Nuclear Medicine
QC-verified PI×1
Ronald Levy
Stanford University
QC-verified PI×6
Stephen Ansell, M.D
North Central Cancer Treatment Group
ROCHESTER, MN
QC-verified PI×4
Bouthaina S Dabaja, M.D
M.D. Anderson Cancer Center
HOUSTON, TX
QC-verified PI×4
Izidore Lossos, MD
University of Miami
MIAMI, FL
QC-verified PI×3
Jillian Gunther, MD
M.D. Anderson Cancer Center
HOUSTON, TX
QC-verified PI×2
Bing Xu, MD, PhD
The First Aiffiliated hosptical of xiamen University
DETROIT, MI
QC-verified PI×2
Jacob D. Soumerai, MD
Massachusetts General Hospital
BOSTON, MA
QC-verified PI×1

More about MALT lymphoma

Disease overview →
Treatments →
Clinical trials →